8,602
Views
73
CrossRef citations to date
0
Altmetric
Research Article

Formulation, in-vitro characterization and clinical evaluation of curcumin in-situ gel for treatment of periodontitis

, , &
Pages 133-142 | Received 19 Jul 2016, Accepted 04 Sep 2016, Published online: 03 Feb 2017

Figures & data

Table 1. In-vitro evaluation of curcumin in-situ gel formulations containing 30% pluronic F127 and 1% carbopol P934, of pH 4 at zero time and after three months storage in refrigerator.

Figure 1. Chemical stability of curcumin in 10% pluronic F127 conc in PBS pH 6.8.

Figure 1. Chemical stability of curcumin in 10% pluronic F127 conc in PBS pH 6.8.

Figure 2. Chemical stability of curcumin in 0.02% and 0.05% pluronic F127.

Figure 2. Chemical stability of curcumin in 0.02% and 0.05% pluronic F127.

Figure 3. Stability profile of curcumin in the release medium (ethanol:water 1:1).

Figure 3. Stability profile of curcumin in the release medium (ethanol:water 1:1).

Figure 4. In-vitro release study of curcumin in-situ gel formulations: (a) without neutralization; (b) with neutralization.

Figure 4. In-vitro release study of curcumin in-situ gel formulations: (a) without neutralization; (b) with neutralization.

Table 2. Release Models for the selected formulation with and without neutralization.

Figure 5: Drug release profiles of Cur in-situ gel formulations subjected to a stability study in refrigerator, for 3 months. (a) G1 containing 1% suspended Cur formulation, (b) G2 containing 2% suspended Cur formulation, (c) G3 containing 1% dissolved Cur formulation and (d) G4 containing 2% dissolved Cur formulation.

Figure 5: Drug release profiles of Cur in-situ gel formulations subjected to a stability study in refrigerator, for 3 months. (a) G1 containing 1% suspended Cur formulation, (b) G2 containing 2% suspended Cur formulation, (c) G3 containing 1% dissolved Cur formulation and (d) G4 containing 2% dissolved Cur formulation.

Figure 6. Drug content of Cur in-situ gel formulations subjected to a stability study in refrigerator, for 3 months.

Figure 6. Drug content of Cur in-situ gel formulations subjected to a stability study in refrigerator, for 3 months.

Table 3. Comparison between the two studied groups according to pocket depth (PD), bleeding index, plaque index (PI) at base line and after one month treatment.